ROR1 and B-cell chronic lymphocytic leukemia: In order to test if Lyn controls ROR1 trafficking or endocytosis to reduce ROR1 surface dynamics and to control chemotaxis, we analyzed the response of CLL cells to the Lyn inhibitor Dasatinib (25 nM).